Banoth Karan Kumar (Karan Kumar Banoth, Banoth K Kumar)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 14

Top Venues

Future medicinal chemistry

RSC advances

RSC medicinal chemistry

Journal of biomolecular structure & dynamics

Birla Institute of Technology and Science

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Birla Institute of Technology and Science Jun 01 2018

India

Research scholar :: Pharmacy

Publications

Adinarayana Nandikolla, Yogesh Mahadu Khetmalis, Boddupalli Venkata Siva Kumar, Ala Chandu, Banoth Karan Kumar, Gauri Shetye, Rui Ma, Sankaranarayanan Murugesan, Scott G Franzblau, Kondapalli Venkata Gowri Chandra Sekhar
Design, synthesis and biological evaluation of phenanthridine amide and 1,2,3-triazole analogues against Mycobacterium tuberculosis . RSC medicinal chemistry 14 (8) (2023)
Yogesh Mahadu Khetmalis, Surendar Chitti, Anjani Umarani Wunnava, Banoth Karan Kumar, Muthyala Murali Krishna Kumar, Sankaranarayanan Murugesan, Kondapalli Venkata Gowri Chandra Sekhar
Design, synthesis and anti-mycobacterial evaluation of imidazo[1,2- a ]pyridine analogues. RSC medicinal chemistry 13 (3) (2022)
Surendar Chitti, Sravani Pulya, Adinarayana Nandikolla, Tarun Kumar Patel, Banoth Karan Kumar, Sankaranarayanan Murugesan, Balaram Ghosh, Kondapalli Venkata Gowri Chandra Sekhar
Design, synthesis and structure-activity relationship studies of novel spirochromanone hydrochloride analogs as anticancer agents. Future medicinal chemistry 14 (5) (2022)
Raja Rajeswari Rajeshkumar, Banoth Karan Kumar, Parasuraman Pavadai, Panneerselvam Theivendren, Krishnan Sundar, Damodar Nayak Ammunje, Sureshbabu Ram Kumar Pandian, Sankaranarayanan Murugesan, Shanmugampillai Jeyarajaguru Kabilan, Selvaraj Kunjiappan
Graph theoretical network analysis, in silico exploration, and validation of bioactive compounds from Cynodon dactylon as potential neuroprotective agents against α-synuclein. BioImpacts : BI 12 (6) (2022)
Adinarayana Nandikolla, Srinivasarao Singireddi, Banoth Karan Kumar, Sankaranarayanan Murugesan, Himanshu Aggarwal, Rafael Balaña Fouce, Melcón-Fernandez Estela, Kondapalli Venkata Gowri Chandra Sekhar
Design, synthesis and evaluation of novel phenanthridine triazole analogs as potential antileishmanial agents. Future medicinal chemistry 14 (12) (2022)
Raja Rajeswari Rajeshkumar, Banoth Karan Kumar, Parasuraman Pavadai, Panneerselvam Theivendren, Krishnan Sundar, Damodar Nayak Ammunje, Sureshbabu Ram Kumar Pandian, Sankaranarayanan Murugesan, Shanmugampillai Jeyarajaguru Kabilan, Selvaraj Kunjiappan
Graph theoretical network analysis, in silico exploration, and validation of bioactive compounds from Cynodon dactylon as potential neuroprotective agents against α-synuclein. BioImpacts : BI 12 (6) (2022)
Joseph Christina Rosy, Ewa Babkiewicz, Piotr Maszczyk, Piotr Mrówka, Banoth Karan Kumar, Sankaranarayanan Murugesan, Kunjiappan Selvaraj, Krishnan Sundar
l-Ornithine-N5-monooxygenase (PvdA) Substrate Analogue Inhibitors for Pseudomonas aeruginosa Infections Treatment: Drug Repurposing Computational Studies. Biomolecules 12 (7) (2022)
Surendar Chitti, Kevin Van Calster, Davie Cappoen, Adinarayana Nandikolla, Yogesh Mahadu Khetmalis, Paul Cos, Banoth Karan Kumar, Sankaranarayanan Murugesan, Kondapalli Venkata Gowri Chandra Sekhar
Design, synthesis and biological evaluation of benzo-[ d ]-imidazo-[2,1- b ]-thiazole and imidazo-[2,1- b ]-thiazole carboxamide triazole derivatives as antimycobacterial agents. RSC advances 12 (35) (2022)
Faheem Faheem, Banoth Karan Kumar, Kondapalli Venkata Gowri Chandra Sekhar, Subhash Chander, Kunjiappan Selvaraj, Sankaranarayanan Murugesan
1,2,3,4-Tetrahydroisoquinoline (THIQ) as privileged scaffold for anticancer de novo drug design. Expert opinion on drug discovery 16 (10) (2021)
Banoth Karan Kumar, Faheem Faheem, Rafael Balana Fouce, Estela Melcon-Fernandez, Yolanda Perez-Pertejo Yolanda, Rosa M Reguera, Nandikolla Adinarayana, Kondapalli Venkata Gowri Chandra Sekhar, Satheeshvarma Vanaparthi, Sankaranarayanan Murugesan
Design, synthesis and evaluation of novel β-carboline ester analogues as potential anti-leishmanial agents. Journal of biomolecular structure & dynamics (2021)
Harsha Kharkwal, Banoth Karan Kumar, Sankaranarayanan Murugesan, Gautam Singhvi, Preeti Avasthi, Ankush Goyal, Joazaizulfazli Jamalis, Subhash Chander
Search for new therapeutics against HIV-1 via dual inhibition of RNase H and integrase: current status and future challenges. Future medicinal chemistry 13 (3) (2021)
Faheem Faheem, Banoth Karan Kumar, Kondapalli Venkata Gowri Chandra Sekhar, Subhash Chander, Kunjiappan Selvaraj, Sankaranarayanan Murugesan
Medicinal chemistry perspectives of 1,2,3,4-tetrahydroisoquinoline analogs - biological activities and SAR studies. RSC advances 11 (20) (2021)
Adinarayana Nandikolla, Singireddi Srinivasarao, Banoth Karan Kumar, Sankaranarayanan Murugesan, Himanshu Aggarwal, Louise L Major, Terry K Smith, Kondapalli Venkata Gowri Chandra Sekhar
Synthesis, study of antileishmanial and antitrypanosomal activity of imidazo pyridine fused triazole analogues. RSC advances 10 (63) (2020)
Banoth Karan Kumar, Faheem Faheem, Kondapalli Venkata Gowri Chandra Sekhar, Rupal Ojha, Vijay Kumar Prajapati, Aravinda Pai, Sankaranarayanan Murugesan
Pharmacophore based virtual screening, molecular docking, molecular dynamics and MM-GBSA approach for identification of prospective SARS-CoV-2 inhibitor from natural product databases. Journal of biomolecular structure & dynamics (2020)

Banoth Karan Kumar.css-eqlu8i{font-size:small;padding-left:4px;} (Karan Kumar Banoth, Banoth K Kumar)

Publication Activity (10 Years)

Top Topics

Top Venues

Banoth Karan Kumar (Karan Kumar Banoth, Banoth K Kumar)